Grants and Contributions:
Title:
Validation of Novel Treatment for Incontinence-Related Skin Damage
Agreement Number:
1020205
Agreement Value:
$173,100.00
Agreement Date:
Jun 1, 2024 - Jan 4, 2027
Description:
Three studies will be conducted; study 1 is a pilot that aims to de-risk studies 2 and 3 by validating a novel monitoring tool, the IAD-ITD-M, for nurses to assess and track moisture-associated skin damage (MASD) caused by incontinence, distinguishing it from other conditions. Studies 2 and 3 evaluate the safety and efficacy of a proprietary cream (DermaShield) – containing a natural plant extract - in treating MASD from diarrhea or fecal incontinence, hypothesizing improved healing compared to the standard of care.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Port Williams, Nova Scotia, CA B0P 1T0
Reference Number:
172-2024-2025-Q2-1020205
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
739815330
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 350 days. The total amended value is -14,900 dollars.
Amendment Date
Nov 25, 2025
Recipient's Legal Name:
Scotiaderm Inc.
Federal Riding Name:
Kings--Hants
Federal Riding Number:
12007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: